Fri Feb 18, 2011, 01:37 PM
|
|
Member
|
|
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918
|
|
|
Vidaza
Hi Karen,
You know these posts are old. This info is more up to date: "Patients who received seven consecutive days had a higher overall response rate of 74%, compared with 65% for 5/2/2 or 58% for 5 days. Given the survival benefit and acceptable tolerability data from AZA-001, higher risk patients with MDS with AZA should be treated without reducing the dose or number of treatment days from the 75 mg/m2, 7-day schedule whenever possible".http://asheducationbook.hematologyli...ull/2010/1/314
Kind regards
Birgitta-A |